These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18584574)

  • 1. The effects of levetiracetam on alcohol consumption in alcohol-dependent subjects: an open label study.
    Sarid-Segal O; Piechniczek-Buczek J; Knapp C; Afshar M; Devine E; Sickles L; Uwodukunda E; Richambault C; Koplow J; Ciraulo D
    Am J Drug Alcohol Abuse; 2008; 34(4):441-7. PubMed ID: 18584574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients.
    Fertig JB; Ryan ML; Falk DE; Litten RZ; Mattson ME; Ransom J; Rickman WJ; Scott C; Ciraulo D; Green AI; Tiouririne NA; Johnson B; Pettinati H; Strain EC; Devine E; Brunette MF; Kampman K; A Tompkins D; Stout R;
    Alcohol Clin Exp Res; 2012 Aug; 36(8):1421-30. PubMed ID: 22324516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam in the treatment of alcohol dependence: toward the end of the story?
    Le Strat Y
    Alcohol Clin Exp Res; 2012 Aug; 36(8):1309-10. PubMed ID: 22823576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anticonvulsant levetiracetam potentiates alcohol consumption in non-treatment seeking alcohol abusers.
    Mitchell JM; Grossman LE; Coker AR; Messing RO
    J Clin Psychopharmacol; 2012 Apr; 32(2):269-72. PubMed ID: 22367657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam for the treatment of co-occurring alcohol dependence and anxiety: case series and review.
    Mariani JJ; Levin FR
    Am J Drug Alcohol Abuse; 2008; 34(6):683-91. PubMed ID: 18850500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of levetiracetam for outpatient alcohol detoxification.
    Müller CA; Schäfer M; Schneider S; Heimann HM; Hinzpeter A; Volkmar K; Förg A; Heinz A; Hein J
    Pharmacopsychiatry; 2010 Jul; 43(5):184-9. PubMed ID: 20503149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of levetiracetam for the prevention of alcohol relapse in recently detoxified alcohol-dependent patients: a randomized trial.
    Richter C; Effenberger S; Bschor T; Bonnet U; Haasen C; Preuss UW; Heinz A; Förg A; Volkmar K; Glauner T; Schaefer M
    J Clin Psychopharmacol; 2012 Aug; 32(4):558-62. PubMed ID: 22722516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol preferring rats chronically treated with levetiracetam: a preliminary study.
    Zalewska-Kaszubska J; Bajer B; Czarnecka E; Dyr W; Gorska D
    Physiol Behav; 2011 Mar; 102(5):538-41. PubMed ID: 21187108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical studies with the novel anticonvulsant levetiracetam in mouse brain.
    Sills GJ; Leach JP; Fraser CM; Forrest G; Patsalos PN; Brodie MJ
    Eur J Pharmacol; 1997 Apr; 325(1):35-40. PubMed ID: 9151936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot tolerability and effectiveness study of levetiracetam for postherpetic neuralgia.
    Rowbotham MC; Manville NS; Ren J
    Neurology; 2003 Sep; 61(6):866-7. PubMed ID: 14504347
    [No Abstract]   [Full Text] [Related]  

  • 11. Levetiracetam: treatment in epilepsy.
    Ben-Menachem E
    Expert Opin Pharmacother; 2003 Nov; 4(11):2079-88. PubMed ID: 14596661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy.
    Nakken KO; Eriksson AS; Lossius R; Johannessen SI
    Seizure; 2003 Jan; 12(1):42-6. PubMed ID: 12495648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label pilot study of levetiracetam for essential tremor.
    Ondo WG; Jimenez JE; Vuong KD; Jankovic J
    Clin Neuropharmacol; 2004; 27(6):274-7. PubMed ID: 15613931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.
    De Smedt T; Raedt R; Vonck K; Boon P
    CNS Drug Rev; 2007; 13(1):57-78. PubMed ID: 17461890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H; Matagne A; Gobert J; Wülfert E
    Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Levetiracetam: a molecule with a novel mechanism of action in the pharmaceutical treatment of epilepsy].
    Szökó E
    Ideggyogy Sz; 2002 May; 55(5-6):195-6. PubMed ID: 12122879
    [No Abstract]   [Full Text] [Related]  

  • 17. Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders.
    Knapp CM; Ciraulo DA; Sarid-Segal O; Richardson MA; Devine E; Streeter CC; Oscar-Berman M; Surprise C; Colaneri L; Putnam M; Waters M; Richambault C
    J Clin Psychopharmacol; 2015 Feb; 35(1):34-42. PubMed ID: 25427171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of levetiracetam for patients with panic disorder: results of an open-label, fixed-flexible dose study.
    Papp LA
    J Clin Psychiatry; 2006 Oct; 67(10):1573-6. PubMed ID: 17107249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy.
    Neyens LG; Alpherts WC; Aldenkamp AP
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):411-9. PubMed ID: 7624492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam: the profile of a novel anticonvulsant drug-part I: preclinical data.
    De Smedt T; Raedt R; Vonck K; Boon P
    CNS Drug Rev; 2007; 13(1):43-56. PubMed ID: 17461889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.